Skip to Main Content

ManagedCareEye.com

This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Home
CE Activities
Faculty
Expert Updates
Outcomes
Resources

PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases

December 12, 2023

FEATURING: Garvin H. Davis, MD, Jeffrey Dunn, PharmD, MBA

← PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm Retinopathy of Prematurity (ROP) –Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area →

About Impact Education, LLC
Contact Us (IMPACT)
Mailing List (IMPACT)
Privacy Policy

Jointly provided by

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.